Toggle navigation
Home
Search
Services
Blog
Contact
About
Mechanism of Toxicity of Diquat
Spalding, David J.
Baylor College of Medicine, Houston, TX, United States
Search 6 grants from David Spalding
Search grants from Baylor College of Medicine
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Probing the contribution of amygdala-cortical circuits to expectation-guided behavior.
Neuroanatomical markers of persistence versus remission of ADHD
Childrens Cancer Group
AIDS Mental Health Training Program
FRG: Collaborative Research: Emerging issues in the sciences involving non standard diffusion
Recently added grants:
Targeted Small Molecule Inhibitors for Inv(16) Leukemia
BCLW in lymphoma survival and resistance to targeted BCL2 family therapies
Non-Syndromic Hearing Loss A Collaborative Study
Integration of acoustic and electric hearing within or across ears
Mitochondrial function and dysfunction in hair cells
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
International Research Fellowships (FIC) (F05)
Project #
3F05TW003922-01S1
Application #
3021278
Study Section
(BI)
Project Start
1989-06-01
Project End
Budget Start
1989-06-01
Budget End
1989-09-30
Support Year
1
Fiscal Year
1989
Total Cost
Indirect Cost
Institution
Name
Baylor College of Medicine
Department
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Related projects
NIH 1989
F05 TW
Mechanism of Toxicity of Diquat
Spalding, David J. / Baylor College of Medicine
NIH 1987
F05 TW
Mechanism of Toxicity of Diquat
Spalding, David J. / Baylor College of Medicine
Publications
Spalding, D J; Mitchell, J R; Jaeschke, H et al.
(1989)
Diquat hepatotoxicity in the Fischer-344 rat: the role of covalent binding to tissue proteins and lipids.
Toxicol Appl Pharmacol 101:319-27
Comments
Be the first to comment on David Spalding's grant